Cargando…
Emerging Effects of IL-33 on COVID-19
Since the start of COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more than 6 million people have lost their lives worldwide directly or indirectly. Despite intensified efforts to clarify the immunopathology of COVID-19, the key factors and processes that t...
Autores principales: | Gao, Yuan, Cai, Luwei, Li, Lili, Zhang, Yidan, Li, Jing, Luo, Chengliang, Wang, Ying, Tao, Luyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658128/ https://www.ncbi.nlm.nih.gov/pubmed/36362440 http://dx.doi.org/10.3390/ijms232113656 |
Ejemplares similares
-
IL-33 Alleviated Brain Damage via Anti-apoptosis, Endoplasmic Reticulum Stress, and Inflammation After Epilepsy
por: Gao, Yuan, et al.
Publicado: (2020) -
The Controversial Role of IL-33 in Lung Cancer
por: Yang, Keshan, et al.
Publicado: (2022) -
IL-33 Depletion in COVID-19 Lungs
por: Gaurav, Rohit, et al.
Publicado: (2021) -
IL-33 in COVID-19: friend or foe?
por: Liang, Yuejin, et al.
Publicado: (2021) -
Emerging roles for IL-25 and IL-33 in colorectal cancer tumorigenesis
por: Jou, Eric, et al.
Publicado: (2022)